News and Articles
Gene Therapy: A New Frontier in Medical Innovation
It is no surprise that one of the most impactful health stories of 2023, as reported by Scientific American, is gene therapy, specifically the approval by the U.S. Food and Drug Administration (FDA) of a groundbreaking gene therapy treatment for sickle cell disease using a novel genome editing technology called CRISPR. While the treatment highlighted…
Using a “Wearable Witness” in Your Next Case
Wearable devices have come a long way from the 13th century’s invention of eyeglasses. The first wearable computer was created in 1960, launched by the notable brand Casio which marketed the first calculator wristwatch. Fast forward to today, where wearable devices can now gather extensive data, specifically about our bodily systems, including exercise, food consumption,…
Artificial Intelligence (AI) in Life Sciences and Healthcare
AI appeared to burst onto the scene in early 2023 and seems to be everywhere, all at once. In reality, AI technology has been integrated into our daily lives for a number of years, most visibly as experienced through the virtual assistants, Siri and Alexa, and its use in medical diagnostic software systems. According to…
Navigating Pharmaceutical Supply Chain Challenges
What did we learn from the story of the Three Little Pigs, each building houses of different materials in the face of a threat? Though not specifically intended as an education in business, the story does teach that recognizing a threat and planning to avoid or mitigate the negative impacts go a long way. In…
Celebrating Hispanic Heritage Month Part 2, with Berkley Life Sciences’ Ioanis González-Rodríguez
In honor of National Hispanic Heritage Month, we asked Ioanis González-Rodríguez, better known as “E,” a Life Sciences Associate here at BLS, if he would share his experiences about his Hispanic background and what this month means to him. E, what are some of your favorite traditions or cultural celebrations significant to your Hispanic culture?…
Celebrating National Hispanic Heritage Month with Berkley Life Sciences’ Angie Rodriguez
In honor of National Hispanic Heritage Month, we asked Angelica “Angie” Rodriguez, Berkley Life Sciences’ Life Science Specialist, if she would share her experiences about her Hispanic culture, traditions, role models, diversity, and what this month means to her. She proudly accepted. Angie, can you share any cultural traditions or customs that you practice…
What is Combustible Dust & How to Prevent It
What is Combustible Dust? Combustible dust is any finely divided solid material (wood, plastics, paper, rubber, combustible metals, etc.) that can present an explosion hazard when suspended in air or when accumulated in a confined space and subject to pressure build-up. Examples of combustible dust include aluminum and magnesium: they do not easily burn as…
PFAS “Forever Chemicals” in Medical and Life Sciences Products – Who Should Be Worried?
(It all began with Teflon…) Per- and poly-fluoroalkyl substances (PFAS) are synthetic chemicals that may be toxic to human health. PFAS accumulate in the environment, such as in waterways, in the fish that swim in those waterways, and in public drinking water systems. Blood serum tests of male and female subjects between the ages of…
Defining Scientific Perishable Property: How to Evaluate and Protect it
Examples of Perishable Property Life Science organizations often maintain or work with perishable property critical to the company’s ongoing operations. Perishable property refers to a business’s personal property that is susceptible to spoilage, rapid decay, or deterioration, often due to an unwanted change in environmental conditions. Examples of perishable property used by life science companies…
What the Increase in Decentralized Clinical Trials Means for Your Business
Before COVID-19, decentralized clinical trials (DCTs) adoption was slow due to regulatory factors, technological limitations, and resistance to change within the clinical research community. Since then, the pandemic has acted as a catalyst for the growth of DCTs. Due to the pandemic, many ongoing clinical trials have faced disruptions due to restrictions on participant travel….
